“RegenAphex is the culmination of DPH Biological’s unwavering commitment to unlocking the potential of the biological industry for improving crop production and land stewardship,” said Mick Messman, president and CEO of DPH Biologicals. “We are honored to be recognized by the BioAgTech World Congress and look forward to helping increase product development to meet farmer and consumer demand for more sustainable practices.”
First selected by the Congress Scientific Committee, finalists presented to a live-voting audience. During his presentation, Messman detailed RegenAphex’s potential to unlock value and accelerate agriculture’s transition to a more balanced biological approach through industry channel collaboration.